Karen Beauchamp
About Karen Beauchamp
Karen Beauchamp is the Director of Health Economic Outcomes Research for Emerging Markets at Bristol-Myers Squibb, with extensive experience in health policy, health economics, and consulting within the healthcare, insurance, and pharmaceutical industries.
Current Position at Bristol-Myers Squibb
Karen Beauchamp currently serves as the Director of Health Economic Outcomes Research for Emerging Markets at Bristol-Myers Squibb. Based in the Austin, Texas area, she has been in this role since January 2016. Her work involves leading research initiatives focused on evaluating and improving health outcomes, with a particular emphasis on emerging markets.
Previous Role at Humana
Before joining Bristol-Myers Squibb, Karen worked at Humana, initially as a Strategic Consultant for Humana Pharmacy Solutions from 2008 to 2013. Later, she expanded her responsibilities and continued as a Strategic Consultant at Humana until 2016, making significant contributions to the company's strategies over her eight-year tenure.
Experience at Wyeth
Between 2006 and 2008, Karen Beauchamp worked at Wyeth as a Regional Account Manager (RAM). In this role, she managed relationships and strategies across different regions, contributing to Wyeth's pharmaceutical business development during her two-year tenure.
Director of Pharmacy Services at ODS Health Plan, Inc.
From 2000 to 2006, Karen served as the Director of Pharmacy Services at ODS Health Plan, Inc. In this capacity, she oversaw the pharmacy operations and services, ensuring efficient and effective delivery of pharmacy care. Her leadership helped shape the organization's pharmacy service strategies over her six-year term.
Educational Background and Expertise
Karen Beauchamp holds a Bachelor of Science in Pharmacy (BSPharm) from Oregon State University. Her education in pharmacy laid the foundation for her extensive experience in health policy and health economics, especially in the context of Medicare and Medicare Part D. This academic background supports her deep expertise in consulting within the healthcare, insurance, and pharmaceutical industries.